Recent Finacing
Recent Raise
RheumaGen is a Colorado-based biotech developing one-time, HLA-edited cell and gene therapies to cure common autoimmune diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at RheumaGen.